RAC 1.11% $1.83 race oncology ltd

RAC Primer, page-112

  1. 1,234 Posts.
    lightbulb Created with Sketch. 2459
    DR T given FTO is such a new discovery and we haven't any real competitors, do you have an idea on how to price the drug?

    I do wonder how you overcome the commercial conversation of pricing Bisantrene as "A better anthracycline" which as you say is only a couple of hundred dollars a dose, does this not bastardize the price and de-value it when you may have a targeted agent drug and your trying to compete with chemo drugs? Do you not need to pick one or the other?

    How then could we compare revenues of Keytruda which according to the website places a treatment every 3 weeks at around $10k USD>


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.